Français

/ Contact

Search for:

About
Projects
Strategic Support
Entrepreneurship
News
Careers
Media Tools

Clinical Development

Ribavirin in Leukemia

For further informations

Steven J. Klein Ph.D., MBA
Vice-president, Business Development
steven.klein@iricor.ca
T +1 514 343.6647

Objective	To develop
Principal Investigator	Kathy Borden

Competitive Advantages

Project Overview

Our
Partners

Domain Therapeutics

Bristol-Myers Squibb

© 2008-2021 IRICoR